Preface, Acknowledgment of Contributors, PART I: General Information on Cancer Staging and End-Results Reporting, Purposes and Principles of Cancer Staging, Cancer Survival Analysis, PART II: Head and Neck, Lip and Oral Cavity, Pharynx, Larynx, Nasal Cavity and Paranasal Sinuses, Major Salivary Glands (Parotid, Submandibular, and Sublingual), Thyroid, Mucosal Melanoma of the Head and Neck, PART III: Digestive System, Esophagus and Esophagogastric Junction, Stomach, Small Intestine, Appendix, Colon and Rectum, Anus, Gastrointestinal Stromal Tumor, Neuroendocrine Tumors, Liver, Intrahepatic Bile Ducts, Gallbladder, Perihilar Bile Ducts, Distal Bile Duct, Ampulla of Vater, Exocrine and Endocrine Pancreas, PART IV: Thorax, Lung, Pleural Mesothelioma, PART V: Musculoskeletal Sites, Bone, Soft Tissue Sarcoma, PART VI: Skin, Cutaneous Squamous Cell Carcinoma and Other Cutaneous Carcinomas, Merkel Cell Carcinoma, Melanoma of the Skin, PART VII: Breast, Breast, PART VIII:Â Gynecologic Sites, Vulva, Vagina, Cervix Uteri, Corpus Uteri, Ovary and Primary Peritoneal Carcinoma, Fallopian Tube, Gestational Trophoblastic Tumors, PART IX: Genitourinary Sites, Penis, Prostate, Testis, Kidney, Renal Pelvis and Ureter, Urinary Bladder, Urethra, Adrenal, PART X: Lymphoid Neoplasms, Hodgkin and Non-Hodgkin Lymphomas, Primary Cutaneous Lymphomas.